Evaluation of effectiveness of category – II regimen under revised national tuberculosis control programme

 

 

REFERENCES

1. Research for Action, Understanding and controlling tuberculosis in India, WHO 2000.
2. Dye et al Global Burden of Tuberculosis, Estimated Incidence, Prevalence, Mortality by Country Jama 1999, 282, 677-686.
3. Ahlburg D, The economic impact of tuberculosis Geneva, WHO 2000 (WHO / CDS/STS/2005)
4. RaviglioneMc et al Tuberculosis, HIV Current status in Africa AIDS 1997
5. Manual on Isolation, Identification, sensitivity testing of mycobacterium tuberculosis, 2nd Edition 1998: NTI, Bangalore.
6. Central TB Division; Directorate General of Health Services, NirmanBhavan, New Delhi.
7. Revised International definitions in TB control Int. J. Tuberc Lung Dis. 2001 5(3): 213.
8. Frieden TR, Sherman LF, Maw KL, et al . A multi institutional out break of highly drug resistant tuberculosis, epidemiology and clinical outcomes. JAMA 1996; 276: 1229-1235
9. Reider HL Drug resManual on Isolation, Identification, sensitivity testing of mycobacterium tuberculosis, 2nd Edition 1998: NTI, Bangalore.
10. Resistant tuberculosis; issues in epidemiology and challenges health tubercle lung dis 1993; 75; 321-323.
11. Iseman MD, madsen LA, Drug resistant tuberculosis. Clin chest Med 1989; 10;
12. Geng E, Kreiswirth B, Driver C, LiJ et al. Changes in transmission of tuberculosis in Newyork city from 1990 to 1999 N Engl J Med 2002; 346.
13. Deivanayagam CN, Rajasekharan S, Venkatesan R et al. Prevalence of acquired MDR – TB and HIV co infection Indian J. Chest Dis Allied Sci 2002: 44.
14. Snider DE (Jr) La Montagne JR. the neglected global tuberculosis problem. A report of the1992 world congress on tuberculosis with infectious dis 1994; 169.MA.Espinal, K.Laserson
15. W. Pleumpanupat, S. Jithimanee et al. Resistance to anti-tuberculosis drugs among smear positive cases in thai prisons 2 years after the implementation of the dots strategy. Int. J.Tuberc lung dis 7(5) 2003.
16. M. Gninafon, L, TawoF.Kassa, et al. Outcome of tuberculosis retreatment in routine conditions in Cotonou, Benin Int. J. Tuberc. Lung Dis 2004 8(10)
17. E. Heldal T. Arnadottir et al. Low failure rate in standardised retreatment of tuberculosis in Nicargua. Int. J.Tuber lung dis 2001 5(2) 129-136.
18. Oguzkarabay, Metiotkun et al Anti-tuberculosis drug resistance and associated risk factors in the European section of turkey. Ind. J. of chest disalliedscienvol 46 No.3 2004.
19. BenDov I, Mason GR, Drug resistant tuberculosis in a southern Californian hospital. Trends from 1969 to 1984. Am rev resp. dis 1987, 135.
20. Fischl MA, Daikos GL, et al. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple drug resistant bacilli. Ann. Interm med 1992.
21. Friden TR, sterling T, et al. The emergence of drug resistant tuberculosis in Newyork city.N.Eng/J.Med1993 , 328
22. Sophiavijay, V.H.Balasangameshwara et al. Retreatment outcome of smear positive tuberculosis cases under dots in Bangalore city. Ind.J.Tub 2002, 49,195.
23. C.Kuaban, R.Bercion et al. Acquired antituberculosis drug resistance in yaounde, cameroon Int. J.Tuberc.Lung dis 2000 4 (5) 427-432.
24. Ridzon R, whithey CG, Mckenna MT, et al. Risk factors for rifampicin monoresistant tuberculosis. An.J.Respircrit care Med 1998.
25. Munsiff S, S. Joseph, et al. Rifampicin monoresistant tuberculosis in New York city, 1993-94 clininfec dis 1997.
26. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance WHO/TB/97.229 Geneva 1997.
27. Shah AR, Agarwal SK, shah KV study of drug resistance in previously treated tuberculosis patients in Gujarat India. Int. J. Tuber lung dis 2002,6: 1098.Mohan A, Sharma SK, Epidemiology Tuberculosis, New Delhi 2001.P 14-29.
28. C. Kusaban, R. Bercion et al. Acquired anti-tuberculosis drug resistance n Yaounde, Cameroon. Int. J. Tuberc lung Dis;2000;4 (5) 427-432.
29. Z. ZWolska, E.Augustynowicz-kopel, M.Klatt primary and acquired drug resistance in polish tuberculosis patients. Int. J. Taberc lung dis 4 (9) 2000
30. R.N. Mania, Jyothipatnaik, et al. Results of category II dots regimen in three tribal districts of Orissa Ind. J. of TB 2001, 48.
31. H.T.W. Quy., N.T.N.Lan, M.W. Borgdorff. et al. Drug resistance among failure and relapse cases of tuberculosis; is the standard retreatment regimen adequate int.J.Tubere lung Dis 7 (7) 631-636 2003.
32. Kimerling ME, Kluge H. et al. Adequacy of the current WHO retreatment regimen in a central Siberian prison treatment failure and MDR TB Int. J. Tuberc lung Dis 1999;3;451-453.
33. Lan NTN, Iademarlo ME, Binkin NJ, et al. A case series.Initial outcome of persons with multidrug resistant tuberculosis after treatment with the WHO standard retreatment regimen in HoChin Minh Vietnam. Int. J. Tuberc Lung dis 2001; 5; 575-578.
34. J.C.Saravia, S.C.Appleton, M.L.Rich et al retreatment management strategies when first line tuberculosis therapy fails. Int. J. Tuber lung dis 2005 9 (4).
35. K.C.Chang, CC Lung, CM Tam with am risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong-Kong. Int. J. Tuber. Lung Dis 2004 8(12)
36. Santha T, Garg R, frieden TR, et al. Risk factors associated with defaults, failure and death among tuberculosis patients treated in a dots programme in Tiruvallur district south India, 2000. Inj.J. Tuberc.Lung Dis. 2002 (6).
37. O’Brien JK, Sandman I.A. Keriswirth et al. DNA fingerprinting from mylocacterium tuberculosis isolates of patients confined for therapy, non-compliance shows frequent clustering chest 1997-112.
38. W. PleumPanupat, S. Jittimanee et al resistance to anti-tuberculosis drugs among smear positive cases in thai prisons 2years after the implementation of the DOTS strategy. Int. J. Tuberc Lung Dis 2003 7 (5
39. Alraj hi AA, Abdul wahals, et al. Risk factors for drug resistant mycobacterium tuberculosis in Saudi Med J 2002, 23
40. Sharma SK, TURAGA KK, et al. Clinical and genetic risk factors for the development of MDR TB in non-HIV infected at a tertiary care centre in India a case control study. Infect genet evolu. 2003; 3.